A detailed history of Hcr Wealth Advisors transactions in Amgen Inc stock. As of the latest transaction made, Hcr Wealth Advisors holds 4,742 shares of AMGN stock, worth $1.25 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,742
Previous 4,761 0.4%
Holding current value
$1.25 Million
Previous $1.49 Million 2.69%
% of portfolio
0.2%
Previous 0.21%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$309.38 - $337.38 $5,878 - $6,410
-19 Reduced 0.4%
4,742 $1.53 Million
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $39,938 - $48,535
152 Added 3.3%
4,761 $1.49 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $13,443 - $16,228
-50 Reduced 1.07%
4,609 $1.31 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $55,998 - $63,172
219 Added 4.93%
4,659 $1.34 Million
Q3 2023

Oct 20, 2023

SELL
$218.65 - $271.46 $1,530 - $1,900
-7 Reduced 0.16%
4,440 $1.19 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $22,903 - $29,101
-100 Reduced 2.2%
4,447 $1.17 Million
Q1 2022

May 05, 2022

SELL
$219.27 - $242.57 $46,046 - $50,939
-210 Reduced 4.41%
4,547 $1.1 Million
Q4 2021

Feb 04, 2022

BUY
$198.88 - $227.6 $2,187 - $2,503
11 Added 0.23%
4,757 $1.07 Million
Q3 2021

Nov 02, 2021

BUY
$212.27 - $248.7 $87,030 - $101,967
410 Added 9.46%
4,746 $1.01 Million
Q2 2021

Jul 21, 2021

SELL
$233.58 - $259.14 $37,372 - $41,462
-160 Reduced 3.56%
4,336 $1.06 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $155,337 - $181,020
-700 Reduced 13.47%
4,496 $1.12 Million
Q4 2020

Feb 04, 2021

SELL
$216.38 - $257.67 $4,111 - $4,895
-19 Reduced 0.36%
5,196 $1.2 Million
Q3 2020

Nov 05, 2020

SELL
$234.65 - $260.95 $122,018 - $135,694
-520 Reduced 9.07%
5,215 $1.33 Million
Q2 2020

Jul 30, 2020

BUY
$197.81 - $242.74 $15,429 - $18,933
78 Added 1.38%
5,735 $1.45 Million
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $72,713 - $96,438
-399 Reduced 6.59%
5,657 $1.15 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $210,212 - $270,195
1,111 Added 22.47%
6,056 $1.46 Million
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $183,686 - $220,094
-1,055 Reduced 17.58%
4,945 $957,000
Q2 2019

Jul 25, 2019

SELL
$166.7 - $195.41 $115,689 - $135,614
-694 Reduced 10.37%
6,000 $1.11 Million
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $230,609 - $259,947
1,275 Added 23.53%
6,694 $1.04 Million
Q4 2018

Jan 31, 2019

SELL
$178.4 - $208.25 $98,120 - $114,537
-550 Reduced 9.21%
5,419 $1.06 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $14,452 - $16,293
-78 Reduced 1.29%
5,969 $1.19 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $94,980 - $106,683
572 Added 10.45%
6,047 $1.12 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $113,009 - $132,066
-667 Reduced 10.86%
5,475 $933,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $16,879 - $18,859
100 Added 1.66%
6,142 $1.07 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $1.01 Million - $1.15 Million
6,042
6,042 $1.13 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hcr Wealth Advisors Portfolio

Follow Hcr Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.